Cargando…
Antitumoral activity of L-ascorbic acid-poly- D,L-(lactide-co-glycolide) nanoparticles containing violacein
It has been demonstrated that tumoral cells have a higher uptake of ascorbic acid compared to normal cells. This differential characteristic can be used as a way to improve the specificity of antitumoral compounds if combined with polymeric drug delivery systems. The aim of this study was to prepare...
Autores principales: | Martins, Dorival, Frungillo, Lucas, Anazzetti, Maristela C, Melo, Patrícia S, Durán, Nelson |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819901/ https://www.ncbi.nlm.nih.gov/pubmed/20161989 |
Ejemplares similares
-
Preparation and Characterization of Poly(D,L-Lactide-co-Glycolide) Nanoparticles
Containing Ascorbic Acid
por: Stevanović, Magdalena M., et al.
Publicado: (2007) -
Biodegradable membrane of poly(l-lactide acid-dioxanone-glycolide) and stereocomplex poly(lactide) with enhanced crystallization and biocompatibility
por: Fan, Tiantang, et al.
Publicado: (2022) -
Antitumor Effect of the Idiotypic Cascade Induced by an Antibody Encapsulated in Poly(d, l‐lactide‐co‐glycolide) Microspheres
por: Ma, Jie, et al.
Publicado: (2001) -
Influence of Hydroxyapatite Surface Functionalization on Thermal and Biological Properties of Poly(l-Lactide)- and Poly(l-Lactide-co-Glycolide)-Based Composites
por: Gazińska, Małgorzata, et al.
Publicado: (2020) -
Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin
por: Cardoso, M. Margarida, et al.
Publicado: (2021)